NASDAQ: NVCN
TSX: NVC
VANCOUVER, Aug. 11, 2015 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced that CEO Alexei Marko is scheduled to present at the Canaccord Genuity 35th Annual Growth Conference on Wednesday, August 12th at 9:30 am ET in Boston, MA.
A live audio webcast of the presentation will be available on the Investors page of Neovasc's website at www.neovasc.com.
About Neovasc Inc.
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products in development include Tiara, for the transcatheter treatment of mitral valve disease and the Neovasc Reducer for the treatment of refractory angina. The Company also sells a line of advanced biological tissue products that are used as key components in third-party medical products including transcatheter heart valves. For more information, visit: www.neovasc.com.
SOURCE Neovasc Inc.
Help employers find you! Check out all the jobs and post your resume.
